Balancing effectiveness, toxicity, and individualization: enfortumab vedotin in advanced urothelial cancer.

ABSTRACT:

SUBMITTER: Wang N 

PROVIDER: S-EPMC11986542 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature